NCT00416208View on ClinicalTrials.gov

Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma

PHASE3CompletedINTERVENTIONAL

Enrollment

154

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions

Multiple Myeloma

Interventions

DRUG

Bortezomib

1.6 mg/m2 i.v. d1 d8 d15 d22 for 4 cycles each of 35 days

Trial Locations (37)

Unknown

Bamberg

Berg

Berlin

Bremen

Dortmund

Dresden

Duisburg

Erlangen

Eschweiler

Frankfurt am Main

Freiburg im Breisgau

Goch

Göttingen

Greifswald

Halle

Hamburg

Hamm

Jena

Karlsruhe

Kempten

Kiel

Kÿln N/A

Lübeck

Magdeburg

Mutlangen

München

Münster

Nuremberg

Oldenburg

Regensburg

Rostock

Stuttgart

Trier

Ulm

Villingen-Schwenningen

Wiesbaden

Würzburg

All Listed Sponsors

lead

Janssen-Cilag G.m.b.H

INDUSTRY

NCT00416208 - Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter